HY-111360-10mg
|
MedChemexpress LLC
|
SPL-707 [CAS 2195361-33-0]
|
|
COVID-19-immunoregulation
|
|
HY-111360-5mg
|
MedChemexpress LLC
|
SPL-707 [CAS 2195361-33-0]
|
|
COVID-19-immunoregulation
|
|
HY-110193-10mg
|
MedChemexpress LLC
|
SPP-86 [CAS 1357349-91-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-110193-100mg
|
MedChemexpress LLC
|
SPP-86 [CAS 1357349-91-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-110193-25mg
|
MedChemexpress LLC
|
SPP-86 [CAS 1357349-91-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-110193-5mg
|
MedChemexpress LLC
|
SPP-86 [CAS 1357349-91-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-110193-50mg
|
MedChemexpress LLC
|
SPP-86 [CAS 1357349-91-7]
|
|
Neuroscience-Neuromodulation
|
|
HY-110193-1mL
|
MedChemexpress LLC
|
SPP-86 [CAS 1357349-91-7] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-12177-10mg
|
MedChemexpress LLC
|
Aliskiren (hemifumarate) [CAS 173334-58-2]
|
|
COVID-19-immunoregulation
|
|
HY-12177-100mg
|
MedChemexpress LLC
|
Aliskiren (hemifumarate) [CAS 173334-58-2]
|
|
COVID-19-immunoregulation
|
|
HY-12177-5mg
|
MedChemexpress LLC
|
Aliskiren (hemifumarate) [CAS 173334-58-2]
|
|
COVID-19-immunoregulation
|
|
HY-12177-50mg
|
MedChemexpress LLC
|
Aliskiren (hemifumarate) [CAS 173334-58-2]
|
|
COVID-19-immunoregulation
|
|
HY-12177-1mL
|
MedChemexpress LLC
|
Aliskiren (hemifumarate) [CAS 173334-58-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-15275-10mg
|
MedChemexpress LLC
|
BMS-265246 [CAS 582315-72-8]
|
|
Cancer-Kinase/protease
|
|
HY-15275-100mg
|
MedChemexpress LLC
|
BMS-265246 [CAS 582315-72-8]
|
|
Cancer-Kinase/protease
|
|
HY-15275-5mg
|
MedChemexpress LLC
|
BMS-265246 [CAS 582315-72-8]
|
|
Cancer-Kinase/protease
|
|
HY-15275-50mg
|
MedChemexpress LLC
|
BMS-265246 [CAS 582315-72-8]
|
|
Cancer-Kinase/protease
|
|
HY-15275-1mL
|
MedChemexpress LLC
|
BMS-265246 [CAS 582315-72-8] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|